Discover Card Execution Note Trust Class A(2011-2) DiscoverSeries Notes Assigned Preliminary 'AAA (sf)' Rating May 11

  • ID: 1806042
  • May 2011
  • Standard & Poors
1 of 3

OVERVIEW Discover Card Execution Note Trust's class A(2011-2) DiscoverSeries issuance is an ABS securitization backed by undivided investor interest in Discover Card Master Trust I's series 2007-CC collateral certificate, which, in turn, is collateralized by receivables generated from designated Discover Card accounts. We assigned our preliminary 'AAA (sf)' rating to the class A(2011-2) notes. The preliminary 'AAA (sf)' rating reflects our view of the transaction's credit support, payment and legal structures, and pool characteristics, among other factors. NEW YORK (Standard & Poor's) May 26, 2011--Standard & Poor's Ratings Services today assigned its preliminary 'AAA (sf)' rating to Discover Card Execution Note Trust's $1.0 billion class A(2011-2) DiscoverSeries notes. The note issuance is an asset-backed securities transaction backed by undivided investor...

Companies mentioned in this report are:
- Discover Card Execution Note Trust

Action: Preliminary Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

- Discover Card Execution Note Trust

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.